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Listeria monocytogenes (LM) is a food-borne pathogen that 
causes a range of clinical syndromes including self-limiting 
gastroenteritis, bacteraemia and central nervous system disease. 
In immunocompetent hosts, the disease profile is usually mild 
and self-limiting, whereas immunocompromised hosts (including 
pregnant women and newborns) suffer severe and invasive forms 
of listeriosis. Numerous case reports of sporadic and epidemic 
human LM infection have been published, mainly from high-income 
countries.[1-4] Of the seven known LM serotypes, four infect humans; 
historically, serotype 4b has been the most common serotype 
associated with LM outbreaks.[5,6]
In South Africa (SA), epidemic listeriosis was first reported from 
Johannesburg in 1977/78, with 14 individuals infected (9 neonates 
and 5 adults) and an overall mortality rate of 43%.[7] In the following 
four decades, few sporadic LM cases and suspected clusters were 
reported. [8,9] Owing to the low background incidence of infection, 
invasive LM infection was not previously a notifiable disease in SA. 
In the first quarter of 2017, a countrywide increase in laboratory-
confirmed LM infections was noted, prompting a large-scale public 
health investigation by the National Institute of Communicable 
Diseases (NICD) to determine the source(s) of infection, the LM 
sequence-type(s) involved and the profile of affected cases. As at 
9 April 2018, 1 011 laboratory-confirmed cases of LM had been 
documented, with a mortality rate of 28% among cases with a 
known outcome (193/691). Most cases to date have been reported 
from Gauteng (59%), Western Cape (12%) and KwaZulu-Natal 
(7%) provinces. Of cases with documented age, 41% (418/1 011) 
were neonates aged ≤28 days, most of whom (96%) experienced 
disease onset in the first week of life.[10] On 4 March 2018, the NICD 
announced that the source of the outbreak had been identified 
as ready-to-eat processed meat products manufactured at the 
Enterprise Foods Polokwane production facility, and a countrywide 
recall of the implicated food products began. Although the LM 
incidence rate has declined dramatically, a further 43 outbreak-
related cases have been confirmed since the recall owing to the 
long disease incubation period, a long refrigeration shelf-life of the 
contaminated products and the possibility of cross-contamination of 
other types of foods in the retail or home setting.[10]
Neonates with LM infection present with severe disease and 
experience high mortality rates.[11,12] Most cases of neonatal listeriosis 
present within 7 days of birth (early-onset disease), although cases 
can occur up to 90 days of life (so-called late-onset disease). Early-
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onset infection tends to present with bacteraemia and higher case 
fatality rates, whereas late-onset disease is more likely to cause 
meningitis and central nervous system sequelae.[11] In Cape Town’s 
Metro East area, newborns with severe bacterial infection or other 
conditions requiring tertiary-level care are referred to the Tygerberg 
Hospital neonatal service. Of the 34 reported neonatal listeriosis 
cases in the Western Cape to date, 12 (35%) were managed at 
Tygerberg Hospital.[10]
Objectives
In this report, we describe the clinical course and outcomes of the 
12 neonates with epidemic listeriosis treated at Tygerberg Hospital, 
comparing them with a historical institutional cohort of sporadic 
neonatal LM cases and international publications reporting epidemic 
neonatal LM.
Methods
Study setting
Tygerberg Hospital in Cape Town, SA, is a tertiary academic medical 
complex with 1 384 beds, including 300 neonatal and paediatric beds. 
The neonatal unit (124 beds) incorporates six clinical areas: an 8-bed 
combined medical/surgical neonatal intensive care unit (NICU), a 
4-bed neonatal high-care unit, 2 acute neonatal wards, 1 low-care 
neonatal ward and 1 kangaroo mother care ward. There are ~8 000 
births[13] and ~2 000 neonatal ward admissions to Tygerberg Hospital 
annually, including both inborn babies and ill neonates (<10 days 
of age) transferred in from peripheral hospitals. The antenatal HIV 
prevalence rate is ~17%, and the low birth weight rate (<2 500 g) was 
37% in 2017.[13]
Investigation for suspected neonatal sepsis
Well preterm (<37 completed weeks) and term neonates with 
maternal indications for sepsis work-up (e.g. chorioamnionitis, 
spontaneous preterm labour) and ill neonates with any clinical, 
radiological and/or laboratory features suggesting infection 
underwent at least one blood culture with/without accompanying 
cerebrospinal fluid (CSF) specimens at the discretion of attending 
clinicians. Symptoms and signs that triggered investigation for sepsis 
included lethargy, apnoea, need for increased respiratory support, 
poor feeding, temperature instability, abdominal distension and a 
raised white cell count or C-reactive protein (CRP) level, among 
others. The unit’s empirical antibiotic therapy regimen for early-onset 
neonatal sepsis is ampicillin plus gentamicin, and for early-onset 
meningitis cefotaxime plus ampicillin.
Blood culture sampling and laboratory analysis
Blood cultures and/or CSF samples were collected using an aseptic 
technique and submitted to the National Health Laboratory Service 
(NHLS) microbiology laboratory at Tygerberg Hospital. Blood 
cultures were incubated at 37°C using the BacT/Alert 3D Microbial 
Identification System (bioMérieux, France). On flagging positive, 
an aliquot of the blood culture broth was used to perform a Gram 
stain. In all cases (including the 12 neonatal LM cases reported 
here, where small Gram-positive bacilli were observed on the Gram 
stain) the microbiology laboratory promptly phoned out results to 
the clinicians. An aliquot of the broth was plated onto blood agar 
plates and incubated in a CO2 incubator at 35°C overnight, and 
a bile aesculin agar was inoculated. Colonies that appeared beta-
haemolytic on blood agar and hydrolysed aesculin were further 
identified using a catalase test and the Vitek 2 automated system 
(bioMérieux). Discrepancies in identification were resolved using the 
BD BBL Crystal Gram positive identification kit (BD, USA) or Vitek 
MS (bioMérieux). Penicillin Etests (bioMérieux) were performed to 
determine the minimum inhibitory concentrations (MICs) for the 
isolates. For CSF samples, a cell count, protein and glucose estimation 
were performed, followed by performance of a Gram stain and 
inoculation of blood and cooked blood agar plates with overnight 
incubation in a CO2 incubator at 35°C. A similar process to that 
described above for blood cultures was followed for identification of 
LM on CSF, resolution of discrepant results and sensitivity testing. 
Blood and CSF isolates confirmed as LM were submitted to the 
national reference laboratory at the NICD for sequence typing from 
mid-August 2017 onwards.
Neonatal sepsis and LM outbreak surveillance  
and management
The Unit for Infection Prevention and Control conducted routine 
surveillance for bloodstream infections (including early-onset 
neonatal sepsis and LM bacteraemia) on the Tygerberg Hospital 
neonatal platform in 2017/18. After declaration of the LM outbreak 
by the National Department of Health, mandatory reporting of 
LM infections to the provincial communicable disease control was 
introduced. For each case, additional demographic and outcome 
data, a case investigation form (including a history of the mother’s 
food intake during pregnancy) and a clinical specimen for sequence 
typing was submitted to the NICD. The infection prevention nurse 
practitioner at our institution co-ordinated reporting of all LM cases 
and communication with hospital staff regarding affected patients. 
In view of several published cases of nosocomial transmission 
of LM infection to neonates,[14-17] an alert to attending clinicians 
was distributed in January 2018 recommending use of contact 
precautions for LM-infected patients.
Literature search terms
We searched PubMed, African Journals Online and Google 
Scholar using the terms ‘neonate’, ‘pregnancy’, ‘listeria’, ‘listeriosis’, 
‘neurolisteriosis’ and ‘outbreaks’ for articles published from 1 January 
1978 to 31 January 2017. We excluded publications that described 
sporadic neonatal LM infections only and epidemics with fewer than 
five neonatal cases reported. Each publication or outbreak database 
record was reviewed to extract the following information (when 
available): year/s reported, country, number of neonates infected, 
mortality rate and predominant serotype/s or sequence type identified.
Study design
Neonatal bloodstream infection episodes occurring between 1 Janu-
ary 2017 and 31 January 2018 were prospectively identified and 
recorded during routine surveillance activities. This dataset was 
searched to identify neonatal LM infections and cross-checked 
against neonatal admission records and the NHLS laboratory list 
of LM isolates on blood and CSF cultures. For calculation of LM 
infection incidence rates (historical and current), we divided the 
number of neonatal LM infections managed at the Tygerberg 
neonatal unit per year by the number of live births at the hospital in 
the same year. Additional demographic data on disease presentation, 
clinical course and therapy were obtained by neonatal folder review. 
Clinical data on the historical cohort of sporadic neonatal LM cases 
were obtained from a recently completed study in our department.[18]
Data handling, statistical analysis and ethical approval
For comparison of patient demographics and outcomes between the 
historical cohort and the current epidemic LM cases, we used Student’s 
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t-tests and Fisher’s exact tests or χ2 tests 
for analysis of continuous and categorical 
variables, respectively. A p-value of <0.05 
was considered statistically significant. Stata 
statistical software version 13.1 (StataCorp, 
USA) was used. Ethical approval and 
waiver of individual informed consent were 
obtained from the Human Health Research 
Ethics Committee of Stellenbosch University 
(ref. no. S13/09/171).
Results
Epidemiology of neonatal LM 
infections at Tygerberg Hospital
Between 2006 and 2016, sporadic LM infec-
tion was confirmed in 13 infants treated 
on the neonatal wards,[18] with a mean 
institutional annual neonatal listeriosis rate 
of 0.17/1 000 live births. From 1 January 
2017 to 31 January 2018, 12 culture-
confimed neonatal listeriosis cases were 
managed on the neonatal platform during 
the countrywide Listeria epidemic, with a 
neonatal listeriosis rate of 1.4/1 000 live 
births in 2017, representing a significant 
increase from the preceding period (p<0.001) 
(Fig. 1). In comparison with other neonatal 
bloodstream infection pathogens by quarter 
of 2017, the proportion of infections caused 
by LM increased significantly in quarters 3 
and 4, equalling or exceeding other early-
onset neonatal sepsis pathogens (Fig. 2).
Case series of neonatal LM during 
the 2017 nationwide epidemic
Twelve mothers from geographically diverse 
areas in the Cape Metro gave birth to 13 
newborns (1 set of twins) (Table 1). LM 
bacteraemia was confirmed by culture in 
12/13 infants, although all received therapy 
for listeriosis. The mothers’ median age was 
31 years (interquartile range (IQR) 29 - 35). 
Caesarean sections were performed in 5/12 
cases (41.7%). Eight of 12 mothers (66.7%) 
delivered at Tygerberg Hospital. Only 2/12 
mothers (16.7%) were HIV-positive (with 
viral loads of 1 345 copies/mL and lower 
than detectable levels, respectively). Among 
the 9/12 mothers (75.0%) who went into 
spontaneous preterm labour, receipt of intra-
partum antibiotics was documented in 6/9 
(66.7%) and unknown in the remaining 3. 
One mother was diagnosed with chorio-
amnionitis, 2 mothers had urinary tract 
infections and 1 mother had reported 
diarrhoea and decreased fetal movements 
1 day prior to delivery. Histology reports 
available on 2 placentas showed macroscopic 
calcifications. No cases of fetal loss or 
stillbirth following maternal listeriosis were 
identified, although there is currently no 
standardised protocol for investigation for 
LM infection in such cases at our institution. 
None of the mothers whose infants had 
culture-confirmed LM infection had growth 
of LM from clinical specimens.
Neonates
The median gestational age for the 12 
newborns with culture-confirmed listeri-
osis (Table 1) was 35 weeks (IQR 33 - 38) 
and the median birth weight was 2 020 g 
(IQR 1 635 - 2 810) (Table 2). A 13th baby 
(twin of a baby with culture-confirmed LM) 
had respiratory distress at birth and an 
elevated CRP level (61 mg/dL) and was fully 
treated for LM infection, although blood and 
CSF cultures were negative.
Of the 12 babies with culture-confirmed 
LM, 9 (75.0%) were premature and of low 
birth weight (<2 500 g). All newborns had 
growth of LM from blood cultures within 
the first 5 days of life, with 6 positive 
cultures (50.0%) on the first day of life. 
Lumbar punctures were performed in all but 
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the 3 newborns who died (2 were too unstable and 1 had severe 
thrombocytopenia). Neurolisteriosis was clinically suspected in 
5/12 newborns (41.7%); however, only a single CSF sample cultured 
LM.
Half of the cohort required invasive ventilatory support and 3 
needed inotropic support. Ten babies had a chest radiograph taken 
on admission: 7/10 had changes in keeping with pneumonia, 2/10 
had features of transient tachypnoea of the newborn, and 1/10 was 
of poor quality (unable to interpret). Fifty percent (6/12) of the 
babies had cranial ultrasound scans. Half of these babies (3/6) had 
scans that were normal for their gestational age. Three babies had 
abnormalities detected. One had resolving grade 1 intraventricular 
haemorrhage (IVH), and another grade 1 IVH with grade 2 - 3 
periventricular leukomalacia (PVL). The third baby had two scans, 
the initial one showing fibrin strands in the lateral ventricles (day 6) 
and a subsequent one demonstrating ventriculomegaly in keeping 
with hydrocephalus, as well as grade 2 PVL (day 15).
All 12 babies underwent laboratory investigations for sepsis on 
hospital admission, with the following results: median CRP 70 mg/
dL (IQR 14 - 298), median white cell count 10 × 109/L (IQR 8 - 15) 
and median platelet count 169 × 109/L (IQR 124 - 241). All 12 
newborns were commenced empirically on intravenous ampicillin 
and gentamicin on hospital admission; those who survived 
completed a total of 21 days on ampicillin, with an initial 7  days 
of gentamicin. In 10/12 cultures where MIC determination was 
performed, the MIC to penicillin was <0.5 μg/mL, i.e. susceptible. 
Only 2 of the 12 neonatal cases’ specimens were processed at the 
NICD for sequence typing; both belonged to sequence type 6 
(ST-6), which has been identified in >90% of the SA LM epidemic 
isolates.[10]
Comparison with the historical cohort
From 2006 to 2016, 13 sporadic cases of listeriosis were managed on 
the Tygerberg Hospital neonatal wards[18] v. 12 epidemic neonatal 
Listeria cases in 2017/18. There was only a single statistically signifi-
cant difference between the cohorts (Table 2): the epidemic cohort 
had a higher incidence of neurolisteriosis and mixed respiratory/
neurological presentations. The sporadic cases experienced a higher 
case fatality rate (62% v. 25%; p=0.075), had a higher proportion of 
neonates admitted to the NICU (92% v. 58%; p=0.073) and included 
more infants who required ventilation (92% v. 50%; p=0.088), 
although these differences did not achieve statistical significance. 
In the historical cohort, 9/13 infants (69.2%) received appropriate 
empirical cover for LM infection with ampicillin (v. 12/12 (100%) 
of the epidemic cohort). When analysing the combined historical 
and epidemic cohort (N=25), factors associated with neonatal 
LM-associated mortality on univariate analysis were being part of 
the historical cohort, need for NICU admission, need for inotropic 
Table 2. Comparison of historical v. epidemic neonatal Listeria cohorts
Total neonatal cases 
(2006 - 2018) (N=25)
Historical cohort  
(2006 - 2016) (N=13)
Epidemic cohort (Jan 
2017 - Jan 2018) (N=12) p-value
Gestational age (wk), median (IQR) 35 (32 - 36) 33 (32 - 35) 35 (32.5 - 37.5) 0.324
Birth weight (g), median (IQR) 2 100 (1 600 - 2 500) 2 200 (1 500 - 2 400) 2 020 (1 635 - 2 810) 0.531
Age at presentation (d), median (IQR) 1 (0 - 2) 1 (0 - 3) 0.5 (0 - 2) 0.563
Length of stay* (d), median (IQR) 19 (12 - 30) 17 (12 - 20) 21 (14 - 30) 0.516
Age at death (d), median (IQR) 2 (1 - 5) 2 (1 - 4.5) 2 (1 - 5) 0.916
Small for gestational age, n (%) 6 (24.0) 4 (30.8) 2 (16.7) 0.363
Gender male, n (%) 8 (32.0) 6 (46.2) 2 (16.7) 0.125
Place of birth peripheral hospital, n (%) 14 (56.0) 10 (76.9) 4 (33.3) 0.036
HIV-exposed, n (%) 6 (24.0) 4 (30.8) 2 (16.7) 0.363
Presenting symptom complex, n (%) 0.039
Respiratory 9 (36.0) 4 (30.8) 5 (41.6)
Neurological 2 (8.0) 0 2 (16.7)
Nonspecific 2 (8.0) 0 2 (16.7)
Combined 12 (48.0) 9 (69.2) 3 (25.0)
Highest level of neonatal care required, n (%) 0.073
Intensive care unit 19 (76.0) 12 (92.3) 7 (58.3)
High-care unit 6 (24.0) 1 (7.7) 5 (41.7)
Respiratory support required, n (%) 0.088
None 2 (8.0) 0 2 (16.7)
nCPAP 5 (20.0) 1 (7.7) 4 (33.3)
IPPV 9 (36.0) 7 (53.8) 2 (16.7)
HFOV 9 (36.0) 5 (38.5) 4 (33.3)
Inotropic support required, n (%) 13 (52.0) 10 (76.9) 3 (25.0) 0.013
Neuroimaging findings, n (%) 0.387
Normal 3 (12.0) 0 3 (25.0)
IVH and/or PVL 4 (16.0) 2 (15.4) 2 (16.7)
Hydrocephalus 4 (16.0) 3 (23.1) 1 (8.3)
No neuroimaging done 14 (56.0) 8 (61.5) 6 (50.0)
Outcome death, n (%) 11 (44.0) 8 (61.5) 3 (25.0) 0.075
IQR = interquartile range; nCPAP = nasal continuous positive airways pressure; IPPV = intermittent positive-pressure ventilation; HFOV = high-frequency oscillatory ventilation;  
IVH = intraventricular haemorrhage; PVL = periventricular leukomalacia.
*Length of stay in tertiary neonatal care.
824       October 2018, Vol. 108, No. 10
IN PRACTICE
support, and high-frequency oscillatory ventilation. In a multivariate 
regression analysis, the requirement for inotropic support was the 
only significant factor predicting mortality (Table 3).
Publications reporting neonatal listeriosis (1978 - 2017)
We identified 15 publications that met our search criteria (Table 4). 
A single report from Africa was identified (in a large teaching 
hospital in SA).[7] Most LM outbreaks described occurred in the 
1980s, with only two outbreaks involving neonates described since 
1990.[28,29] The largest outbreak affected 142 individuals,[2] although 
most reports described small-scale epidemics and one described 
both epidemic and sporadic LM cases affecting neonates.[4] Four 
publications reported neonatal cases only; in the articles describing 
mixed populations, neonates generally made up at least one-third of 
the cases. Overall mortality in neonatal listeriosis was high (mean 
17%, range 0 - 44%). Of publications that reported the LM outbreak 
serotype involved, 1a/b and 4b were most prevalent.
Discussion
We present the only case series of epidemic neonatal listeriosis 
reported from Africa, and compare this cohort with historical 
sporadic neonatal LM cases at our institution and the international 
literature. The only other African case series of epidemic listeriosis 
(adults and neonates) reporting clinical data was also published from 
SA, nearly four decades ago, and involved 9 neonates.[7] The cases 
reported here represent one-third of the neonatal cases identified in 
our province (Western Cape).[10]
The mean pre-epidemic, or historical, incidence of sporadic 
neonatal listeriosis at our institution (2006 - 2016) was 0.17 cases 
per 1 000 live births (annual range 0 - 0.5), substantially exceeding 
Table 4. Published epidemic listeriosis events affecting neonates (1978 - 2017)
Author, year of publication Country
Epidemic ± sporadic 
cases
Year/s 
reported Cases, N
Liveborn 
neonates, 
n (%)
Neonatal 
mortality 
rate*, n (%)
Predominant 
serotype/s† 
Jacobs et al.,[7] 1978 SA Epidemic 1977 - 1978 14 9 (64.3) 4/9 (44.4) 4b
Filice et al.,[19] 1978 USA Epidemic 1975 7 7 (100.0) 0 4b
Schlech et al.,[20] 1983 Canada Epidemic 1981 41 25 (61.0) 7/25 (28.0) 4b
Lennon et al.,[21] 1984 New Zealand Epidemic 1980 22 14 (63.6) 1/14 (7.1) 1b
Malinverni et al.,[22] 1985 Switzerland Epidemic 1983 - 1984 25 11 (44.0) NR 4b
Tulzer et al.,[23] 1987 Austria Epidemic 1986 20 20 (100.0) 5/20 (25.0) 1/2a
Teberg et al.,[24] 1987 USA Epidemic 1986 23 23 (100.0) 5/23 (21.7) NR
Linnan et al.,[2] 1988 USA Epidemic 1985 142 93 (65.5) 10/93 (10.8) 4b
Mascola et al.,[3] 1989 USA Epidemic 1985 - 1986 94 37 (39.4) 6/37 (16.2) 4b and 1a/b
Bucher et al.,[25] 1989 Switzerland Epidemic 1983 - 1987 35 35 (100.0) 5 (14.3) NR
Allerberger et al.,[26] 1989 Austria Epidemic 1986 28 24 (85.7) 5/24 (20.8) NR
Samuelsson et al.,[27] 1990 Denmark Epidemic 1985 - 1987 35 8 (22.9) 1/8 (12.5) NR
Frederiksen and Samuelsson,[4] 1992 Denmark Epidemic + sporadic 1981 - 1988 30 16 (53.3) 2/16 (12.5) 4 and 1
Elcuaz et al.,[28] 1996 Spain Epidemic 1991 - 1993 24 7 (29.2) NR 4 and 1
Pérez-Trallero et al.,[29] 2014 Spain Epidemic 2013 - 2014 27 5 (18.5) 0 1a/b and 4b
SA = South Africa; NR = not reported.
*Total epidemic listeriosis mortality rate = 50/290 (17.2%).
†The serotyping nomenclature was replaced by sequence typing in recent years owing to improved accessibility to molecular typing methods.
Table 3. Factors associated with mortality from neonatal listeriosis (combined historical and epidemic cohorts, N=25)*
Factor
Survived 
(N=14) Died (N=11)
Univariate 
analysis, 
p-value
Multivariate analysis
OR 95% CI p-value
Gestational age (wk), median (IQR) 34 (32 - 37) 35 (31 - 36) 0.847 - - -
Birth weight in (kg), median (IQR) 1.8 (1.2 - 2.6) 2.3 (1.8 - 2.5) 0.311 - - -
Age at presentation (d), median (IQR) 0.5 (0 - 2) 2.0 (0 - 3) 0.180 - - -
Cohort group (historical), n (%) 5 (35.7) 8 (72.7) 0.075 1.1 0.09 - 13.9 0.940
SGA, n (%) 4 (28.6) 2 (18.2) 0.452 - - -
Gender (male), n (%) 9 (64.3) 8 (72.7) 0.496 - - -
Place of birth (Tygerberg Hospital), n (%) 6 (42.9) 8 (72.7) 0.138 - - -
Ampicillin included in empirical antibiotic therapy 
regimen, n (%)
13 (92.9) 9 (81.8) 0.564 - - -
HIV exposure status (HIV-exposed), n (%) 4 (28.6) 2 (18.2) 0.452 - - -
Highest level of care (NICU), n (%) 8 (57.1) 11 (100) 0.017 † † †
Respiratory support (oscillation), n (%) 2 (14.3) 7 (63.6) 0.016 † † †
Inotropic support (required), n (%) 3 (21.4) 10 (90.9) 0.001 34.9 2.3 - 532.1 0.011
SGA = small for gestational age; IQR = interquartile range; NICU = neonatal intensive care unit.
*Factors with a univariate p-value <0.1 were entered into a binary logistic regression model to determine factors significantly associated with Listeria mortality on multivariate analysis.
†Highest level of care and oscillatory ventilation were removed from the model owing to collinearity.
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rates reported from the UK, The Netherlands and the USA (0.05, 
0.01 and 0.09 per 1 000 live births, respectively).[30] Both the 
historical and epidemic listeriosis rates at our institution may be an 
underestimation, as these data reflect laboratory-confirmed cases 
only; some neonates may not have had lumbar punctures performed 
owing to clinical instability, others may have had antibiotics prior to 
blood/CSF culturing, and some may have died before the diagnosis 
was made.
A possible explanation for the apparently high historical rate of 
sporadic neonatal LM infection at Tygerberg Hospital is the use of the 
live births at this tertiary referral neonatal centre as the denominator, 
as opposed to the total population of the hospital’s catchment area. 
An alternative hypothesis is that the high rate of ‘sporadic’ neonatal 
LM may include unrecognised prior outbreaks, as LM infections 
were not notifiable in SA before 2017. Other possible factors that 
may contribute to the comparatively high LM incidence in SA could 
include a more vulnerable population of pregnant women owing 
to high antenatal HIV prevalence,[13] and a higher prevalence of 
LM-contaminated food and water sources than in high-income 
countries.[31-33] Although HIV infection is not traditionally cited as a 
 
 INFECTION PREVENTION AND CONTROL ALERT, 26 JANUARY 2018 
 
Listeriosis outbreak in South Africa  
Implications for neonatal care at Tygerberg Hospital 
 
Target group: Neonatal and obstetric healthcare professionals 
 
By this time you would have heard of the nationwide outbreak of listeriosis in South Africa. 
Since 1 January 2017, 12 neonates in Tygerberg Hospital were treated for Listeria. See attached 
information sheet on listeriosis. 
 
Although most of the babies acquire listeriosis from their mothers (transplacental transfer), 
research shows that it is possible for the organism, Listeria monocytogenes, to be transferred 
between neonates in healthcare. The transmission can already occur in the delivery room by 
means of respiratory equipment that is not cleaned properly after use, other contaminated 
instruments, multi-dose ointments or contaminated supplies. 
 
 
Practice Points 
 
•  Contact precautions: Henceforth all neonates who test positive for Listeria must be placed on 
contact precautions until effective antibiotic treatment has been completed. 
 
•  Respiratory resuscitation equipment (laryngoscope handles, laryngoscope blades, introducers) 
must be cleaned meticulously between patients. Here are the steps for cleaning:  
 
o Wash thoroughly with soap and water. Clean grooves and connection points with a brush. 
o Rinse and dry. 
o Wipe over with 70% alcohol. 
  
Ideally the equipment must be sent to the CSSD for autoclaving. 
 
•  Hand hygiene: Contaminated hands always play an important role in the transfer of infection. 
Make therefore sure that you clean your hands between babies 100% of the time. 
 
•  Neonatal face masks (except the silicone ones) and their tubing are single-use items and must 
NOT be sent to the CSSD for reprocessing. 
 
 
Please report all suspected listeriosis cases (expecting mothers, neonates) to the UIPC. 
 
Fig. 3. Infection prevention clinical alert to obstetric and paediatric staff. (CSSD = Central Sterilisation Supply Department; UIPC = Unit for Infection 
Prevention and Control.)
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risk factor for listeriosis, it emerged as an important risk factor during 
the SA epidemic.[10] However, in our epidemic cohort, only a single 
confirmed antenatal LM infection and two HIV-positive mothers of 
LM neonatal cases were identified.
Historically and during the current outbreak, LM bacteraemia 
events constitute a small percentage of the overall burden of 
bloodstream infections among hospitalised neonates at our 
institution. Even in the outbreak year (2017), the vast majority 
of neonatal bloodstream infections were hospital acquired, with 
LM cases peaking in quarter 3 at 15% of all bacteraemia events. 
However, LM neonatal infections at our institution were associated 
with high mortality (sporadic 62% and outbreak 25%), substantially 
exceeding the published crude fatality rate for neonatal nosocomial 
bloodstream infections at Tygerberg Hospital of 16%.[34] Although 
LM is well documented as a nosocomial pathogen in neonates,[14-17] 
we did not identify any nosocomial LM infections during 2017. Given 
the concerns regarding the potential for nosocomial LM transmission 
and the increasing incidence of neonatal infections in our unit, 
an infection control alert was issued to the hospital’s obstetric and 
neonatal staff (Fig. 3).
Few major differences were observed between the historical 
and epidemic cohorts. In the epidemic cohort there was a larger 
proportion of babies with mixed respiratory and neurolisteriosis 
presentations, although only one baby cultured LM on CSF and just 
3 of 6 cranial ultrasound scans performed had abnormal cranial 
ultrasound findings. However, 2 babies died before cranial ultrasound 
could be performed, and in the third baby who died, the scan was 
performed on day 4 of life, which may have been too early to detect all 
abnormalities. Although not reaching statistical significance owing 
to the small sample size, mortality was much lower in the epidemic 
cohort (25% v. 62%), with a lower proportion of neonates requiring 
NICU admission, mechanical ventilation and inotropic support. In 
a multivariate analysis to identify factors associated with mortality 
from neonatal listeriosis (combined cohorts), the only factor that 
reached significance, with an odds ratio (OR) of 35, was inotropic 
support. However, this probably reflects the group of babies with 
refractory shock who had the most severe disease manifestations. In 
a recently published review of >800 cases of LM infection in neonates 
and adults (the MONALISA study),[1] multiorgan failure was one of 
the strongest predictors of LM-associated mortality (OR 7.98, 95% 
confidence interval 4.3 - 14.7).
In comparison with the global literature, our epidemic LM 
neonatal case fatality rate appears higher than average (25% at 
Tygerberg Hospital v. 16% globally). However, one-third of our 
cohort were severely ill neonates born at peripheral hospitals with 
delayed transfer to our NICU, which may have influenced disease 
outcome. In addition, Tygerberg Hospital is a tertiary referral facility 
caring for complicated obstetric and neonatal cases. Furthermore, 
all 12 babies presented with early-onset disease, which is known 
to be associated with poorer outcome.[11,12] All neonates in the 
epidemic cohort received prompt, appropriate empirical antibiotic 
therapy including ampicillin and gentamicin, which is the locally 
recommended first-line therapy for early-onset neonatal sepsis. Of 
the laboratory investigations submitted at the time of sepsis work-up, 
CRP was elevated (>10 mg/dL) in 12/12 babies (100%), the platelet 
count was reduced (<250 × 109/L) in 9/12 (75.0%), and the total white 
cell count was normal (8 - 25 × 109/L) in most (10/12, 83.3%). In this 
epidemic cohort, raised CRP and reduced platelet count appear to be 
the most useful markers of infection.
Only 2 patients in our cohort had sequence typing results availa-
ble, confirming ST-6 disease, in keeping with >90% of the SA LM 
outbreak isolates. Owing to technological advances in LM strain 
typing approaches, there is a paucity of data on ST-6’s historical 
involvement in outbreaks. However, this sequence type is associated 
with a more severe disease course,[35] and is an additional factor 
that may explain our higher neonatal fatality rate in comparison 
with the published literature. Despite intensive investigation by the 
NICD, no outbreak source/s for the current SA LM epidemic have 
been identified. Although food histories have been obtained from 
many affected patients, no obvious patterns in consumption have 
emerged, with potentially long intervals between consumption of an 
LM-contaminated foodstuff and disease onset.[10]
Study strengths and limitations
The strengths of this study include the use of a clear case definition 
(laboratory-confirmed listeriosis), the detailed description of the 
neonates’ disease course, and comparison with an institutional 
cohort of sporadic neonatal LM cases. However, our study limitations 
include the small cohort size, possible underestimation of the 
epidemic listeriosis rate, limited data on maternal and stillbirth-
associated LM infections, and description of a tertiary hospital cohort 
(representing the sickest neonates with LM who were born in or 
referred to our institution).
Conclusions
Epidemic neonatal listeriosis at Tygerberg Hospital was associated 
with a predominance of bacteraemic disease and severe respiratory 
complications. Listeriosis-associated mortality rates were higher 
than previously published, but lower than the rate in a historical 
institutional cohort. Although we did not identify any cases, 
the documented risk of nosocomial LM transmission warrants 
application of transmission-based precautions for LM cases during 
outbreaks.
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